BioSignal inc. was founded in Montreal in 1992 by Michael Dennis and Guy Lambert.
From the beginning, the BioSignal culture was built on innovation through the production of GPCR tools used to accelerate pharmaceutical research.
Through merger and acquisition, an accomplished team of dedicated scientists emerged to bolster the development of enabling technologies like Alpha and TR-FRET. Much of today’s and tomorrow’s drug discovery relies on tools developed by the Montreal BioSignal team.
Building on these technologies and such a tradition of professionalism, dedication, innovation and teamwork, the BioSignal culture lives through Biopra.